CVS Health Corporation

Our comprehensive AI-powered analysis of CVS Health Corporation (CVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 26.01, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $51.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.13 and a market capitalization of 74.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.